James R Tribble

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Venues

Acta neuropathologica communications

Nature communications

Gene therapy

Journal of clinical medicine

Karolinska Institutet

Cardiff University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Karolinska Institutet May 14 2018

Sweden

Postdoc :: Department of Clinical Neuroscience

Cardiff University Jan 09 2015 - Apr 30 2018

United Kingdom

Postdoctoral research associate :: School of Optometry and Vision Science

Education History

Cardiff University Oct 01 2011 - May 13 2016

United Kingdom

PHD :: School of Optometry and Vision Science

Cardiff University Sep 01 2008 - Jun 01 2011

United Kingdom

BSC :: School of Medicine

Publications

Amin Otmani, Gauti Jóhannesson, Rune Brautaset, James R Tribble, Pete A Williams
Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume. Acta neuropathologica communications 12 (1) (2024)
James R Tribble, Melissa Jöe, Carmine Varricchio, Amin Otmani, Alessio Canovai, Baninia Habchi, Evangelia Daskalakis, Romanas Chaleckis, Andrea Loreto, Jonathan Gilley, Craig E Wheelock, Gauti Jóhannesson, Raymond Ching-Bong Wong, Michael P Coleman, Andrea Brancale, Pete A Williams
NMNAT2 is a druggable target to drive neuronal NAD production. Nature communications 15 (1) (2024)
Amin Otmani, Gauti Jóhannesson, Rune Brautaset, James R Tribble, Pete A Williams
Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume. Acta neuropathologica communications 12 (1) (2024)
James R Tribble, Melissa Jöe, Carmine Varricchio, Amin Otmani, Alessio Canovai, Baninia Habchi, Evangelia Daskalakis, Romanas Chaleckis, Andrea Loreto, Jonathan Gilley, Craig E Wheelock, Gauti Jóhannesson, Raymond Ching-Bong Wong, Michael P Coleman, Andrea Brancale, Pete A Williams
Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production. Nature communications 15 (1) (2024)
Amin Otmani, Gauti Jóhannesson, Rune Brautaset, James R Tribble, Pete A Williams
Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume. Acta neuropathologica communications 12 (1) (2024)
James R Tribble, Melissa Jöe, Carmine Varricchio, Amin Otmani, Alessio Canovai, Baninia Habchi, Evangelia Daskalakis, Romanas Chaleckis, Andrea Loreto, Jonathan Gilley, Craig E Wheelock, Gauti Jóhannesson, Raymond Ching-Bong Wong, Michael P Coleman, Andrea Brancale, Pete A Williams
NMNAT2 is a druggable target to drive neuronal NAD production. Nature communications 15 (1) (2024)
James R Tribble, Melissa Jöe, Carmine Varricchio, Amin Otmani, Alessio Canovai, Baninia Habchi, Evangelia Daskalakis, Romanas Chaleckis, Andrea Loreto, Jonathan Gilley, Craig E Wheelock, Gauti Jóhannesson, Raymond Ching-Bong Wong, Michael P Coleman, Andrea Brancale, Pete A Williams
NMNAT2 is a druggable target to drive neuronal NAD production. Nature communications 15 (1) (2024)
Amin Otmani, Gauti Jóhannesson, Rune Brautaset, James R Tribble, Pete A Williams
Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume. Acta neuropathologica communications 12 (1) (2024)
James R Tribble, Anna Hagström, Kenza Jusseaume, Emma Lardner, Raymond Ching-Bong Wong, Gustav Stålhammar, Pete A Williams
NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve. Acta neuropathologica communications 11 (1) (2023)
Bart Nieuwenhuis, Elise Laperrousaz, James R Tribble, Joost Verhaagen, James W Fawcett, Keith R Martin, Pete A Williams, Andrew Osborne
Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters. Gene therapy (2023)
James R Tribble, Anna Hagström, Kenza Jusseaume, Emma Lardner, Raymond Ching-Bong Wong, Gustav Stålhammar, Pete A Williams
NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve. Acta neuropathologica communications 11 (1) (2023)
Bart Nieuwenhuis, Elise Laperrousaz, James R Tribble, Joost Verhaagen, James W Fawcett, Keith R Martin, Pete A Williams, Andrew Osborne
Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters. Gene therapy (2023)
Bart Nieuwenhuis, Elise Laperrousaz, James R Tribble, Joost Verhaagen, James W Fawcett, Keith R Martin, Pete A Williams, Andrew Osborne
Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters. Gene therapy (2023)
James R Tribble, Anna Hagström, Kenza Jusseaume, Emma Lardner, Raymond Ching-Bong Wong, Gustav Stålhammar, Pete A Williams
NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve. Acta neuropathologica communications 11 (1) (2023)
James R Tribble, Anna Hagström, Kenza Jusseaume, Emma Lardner, Raymond Ching-Bong Wong, Gustav Stålhammar, Pete A Williams
NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve. Acta neuropathologica communications 11 (1) (2023)
James R Tribble, Flora Hui, Melissa Jöe, Katharina Bell, Vicki Chrysostomou, Jonathan G Crowston, Pete A Williams
Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma. Cells 10 (2) (2021)
Tim J Enz, James R Tribble, Pete A Williams
Comparison of Glaucoma-Relevant Transcriptomic Datasets Identifies Novel Drug Targets for Retinal Ganglion Cell Neuroprotection. Journal of clinical medicine 10 (17) (2021)
James R Tribble, Pete A Williams, Bruce Caterson, Frank Sengpiel, James E Morgan
Digestion of the glycosaminoglycan extracellular matrix by chondroitinase ABC supports retinal ganglion cell dendritic preservation in a rodent model of experimental glaucoma. Molecular brain 11 (1) (2018)

James R Tribble.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

James R Tribble